Alexium Accelerates Growth with Microtek Acquisition and Capital Raise

Alexium International Group ( (AU:AJX) ) has shared an announcement.

Alexium International Group reported that in Q2 FY26 it achieved significant milestones in its shift toward scaled commercial operations, highlighted by the acquisition of Microtek Laboratories’ microencapsulation business and technology. The merger creates a vertically integrated mPCM and coatings platform with enhanced manufacturing capacity, a broadened patent portfolio, and the ability to offer a next-generation mPCM product designed to help customers navigate tightening regulatory pressures on certain materials. The company also advanced its flame-resistant textile program for the US military to the field-trial stage, reinforcing its diversification strategy beyond bedding. To support the acquisition and its post-merger growth phase, Alexium completed an entitlement offer raising US$4.6 million to reduce debt and bolster working capital, positioning the company for an expected period of growth and improved results in 2026.

The most recent analyst rating on (AU:AJX) stock is a Sell with a A$0.01 price target. To see the full list of analyst forecasts on Alexium International Group stock, see the AU:AJX Stock Forecast page.

More about Alexium International Group

Alexium International Group operates in the specialty chemicals and advanced materials sector, with a core focus on microencapsulated phase change materials (mPCM) and coatings for the bedding and furniture industries. The company is transitioning from a pure technology and IP development business to a scalable, vertically integrated manufacturing and sales organisation, and is also developing flame-retardant technologies for applications such as US military combat uniform textiles.

Technical Sentiment Signal: Strong Sell

Current Market Cap: A$21.89M

For an in-depth examination of AJX stock, go to TipRanks’ Overview page.